In Silico Drug Design, Molecular Modelling, Synthesis and Characterization of Novel Benzimidazoles
-
Published:19 Nov 2019
-
Special Collection: 2019 ebook collection
R. Sreerama and C. Kaushik, in Conference on Drug Design and Discovery Technologies, ed. M. Murahari, L. Sundar, S. Chaki, V. Poongavanam, P. Bhat, and U. Y. Nayak, The Royal Society of Chemistry, 2019, pp. 271-287.
Download citation file:
Benzimidazole and its scaffolds are considered as an important heterocyclic motif containing two annular nitrogen atoms of bicyclic compound fused with benzene to imidazole ring established and obtained in many synthetic and natural compounds. In recent years, a few marketed drugs containing 1,2,5-trisubstituted benzimidazoles have shown extensive interest with anticancer (Bendamustine), antifungal (Benomyl), analgesic (Etonitazine), antihypertensive (Telmisartan) and antihistaminic (Norastemizole) activities etc. It also exhibits varied pharmaceutical applications resembling antibacterial, antifungal, anti-inflammatory, antitumor, anthelminthic, antihypertensive, anti-HIVs, antiulcer, anti-convulsant, and anti-diabetic activities. In addition, most of the drugs have substitution at 2nd and 5th position at the benzimidazole core. Moreover; at these two positions, substitutions of the benzimidazole moiety were recognized as fundamental for potency of receptor binding and receptor activation.